Drug-Drug Interaction Study to Assess the Effects of Multiple-Dose Administration of K-877 on the Pharmacodynamics and the Pharmacokinetics of Multiple-Dose Administration of Warfarin in Healthy Adult Volunteers

Inclusion Criteria: * Subject provides written informed consent before any study specific evaluation is performed. * Subject is a healthy adult male or female volunteer between the ages of 18 and 45 years, inclusive. * Subject has a body mass index of 18 to 30 kg/m², inclusive. Exclusion Criteria: * Subject has clinically relevant abnormalities in the screening or check in assessments. * Subject has clinically significant out-of-range PT, INR, activated partial thromboplastin time, fibrinogen, protein C, or protein S. * Subject has abnormal prolongation of skin bleeding time at Screening.